Procyon Stock Revenue
| PCYN Stock | USD 0.24 0.01 4.35% |
Procyon fundamentals help investors to digest information that contributes to Procyon's financial success or failures. It also enables traders to predict the movement of Procyon Pink Sheet. The fundamental analysis module provides a way to measure Procyon's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Procyon pink sheet.
Procyon |
Procyon Company Revenue Analysis
Procyon's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Procyon Revenue | 4.84 M |
Most of Procyon's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Procyon is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Procyon reported 4.84 M of revenue. This is 99.94% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The revenue for all United States stocks is 99.95% higher than that of the company.
Procyon is rated top company in revenue category among its peers. Market size based on revenue of Drug Manufacturers—Specialty & Generic industry is at this time estimated at about 4.92 Million. Procyon totals roughly 4.84 Million in revenue claiming about 98% of equities under Drug Manufacturers—Specialty & Generic industry.Procyon Fundamentals
| Return On Equity | -0.0934 | |||
| Return On Asset | -0.0501 | |||
| Profit Margin | (0.05) % | |||
| Operating Margin | (0.07) % | |||
| Current Valuation | 1.82 M | |||
| Shares Outstanding | 8.09 M | |||
| Shares Owned By Insiders | 65.00 % | |||
| Price To Earning | 8.00 X | |||
| Price To Book | 0.77 X | |||
| Price To Sales | 0.40 X | |||
| Revenue | 4.84 M | |||
| Gross Profit | 3.49 M | |||
| EBITDA | (19.2 K) | |||
| Net Income | (209.79 K) | |||
| Cash And Equivalents | 1.04 M | |||
| Cash Per Share | 0.13 X | |||
| Total Debt | 694.3 K | |||
| Debt To Equity | 0.26 % | |||
| Current Ratio | 4.02 X | |||
| Book Value Per Share | 0.31 X | |||
| Cash Flow From Operations | (229.46 K) | |||
| Earnings Per Share | 0.03 X | |||
| Number Of Employees | 19 | |||
| Beta | -0.35 | |||
| Market Capitalization | 2 M | |||
| Total Asset | 3.8 M | |||
| Retained Earnings | (2.46 M) | |||
| Working Capital | 1.04 M | |||
| Current Asset | 1.88 M | |||
| Current Liabilities | 842.7 K | |||
| Z Score | 2.2 | |||
| Net Asset | 3.8 M |
About Procyon Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Procyon's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Procyon using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Procyon based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Procyon
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Procyon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Procyon will appreciate offsetting losses from the drop in the long position's value.Moving against Procyon Pink Sheet
| 0.39 | AAC | Ares Acquisition | PairCorr |
| 0.38 | VII | 7GC Holdings | PairCorr |
| 0.37 | APAC | Stonebridge Acquisition Symbol Change | PairCorr |
The ability to find closely correlated positions to Procyon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Procyon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Procyon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Procyon to buy it.
The correlation of Procyon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Procyon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Procyon moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Procyon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Procyon Pink Sheet
Procyon financial ratios help investors to determine whether Procyon Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Procyon with respect to the benefits of owning Procyon security.